| Lastest Insider Transactions Of ARROWHEAD PHARMACEUTICALS, INC. ( ARWR ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Apel Daniel Joseph | Chief Financial Officer | 2026-04-22 | Sell | 13,095 | 71.35 | 934,285 | 2026-04-24 18:44:42 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2026-04-23 | Sell | 10,000 | 75.00 | 750,000 | 2026-04-24 18:38:34 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2026-03-05 | Sell | 10,000 | 64.19 | 641,900 | 2026-03-09 19:00:06 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO | 2025-12-31 | Sell | 49,493 | 63.11 | 3,123,350 | 2026-01-05 21:50:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO | 2025-12-31 | Sell | 49,493 | 63.11 | 3,123,350 | 2026-01-05 21:50:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2026-01-05 | Sell | 40,164 | 63.11 | 2,534,662 | 2026-01-05 21:41:44 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2026-01-05 | Sell | 40,164 | 63.11 | 2,534,662 | 2026-01-05 21:41:44 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2026-01-02 | Sell | 13,187 | 66.10 | 871,703 | 2026-01-05 21:39:41 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-12-29 | Sell | 51,726 | 69.13 | 3,575,575 | 2025-12-30 17:46:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-12-29 | Option Exercise | 51,726 | 6.15 | 318,115 | 2025-12-30 17:46:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2025-12-26 | Sell | 7,530 | 70.00 | 527,100 | 2025-12-30 17:46:28 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2025-12-19 | Sell | 8,367 | 67.65 | 566,038 | 2025-12-23 18:01:44 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2025-12-19 | Sell | 10,040 | 67.68 | 679,491 | 2025-12-23 18:01:37 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-12-19 | Sell | 26,031 | 68.04 | 1,771,022 | 2025-12-23 18:01:31 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Directior | 2025-12-19 | Sell | 10,000 | 67.66 | 676,623 | 2025-12-23 18:01:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-12-17 | Sell | 85,000 | 64.04 | 5,443,462 | 2025-12-19 18:56:33 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-12-12 | Sell | 184,298 | 67.00 | 12,348,802 | 2025-12-16 13:14:48 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Directior | 2025-12-05 | Sell | 16,250 | 61.03 | 991,738 | 2025-12-09 18:04:27 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2025-11-28 | Sell | 8,750 | 56.39 | 493,413 | 2025-12-01 18:10:20 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2025-10-01 | Sell | 20,000 | 35.00 | 700,000 | 2025-10-03 18:15:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2025-10-01 | Sell | 20,000 | 35.00 | 700,000 | 2025-10-03 18:15:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2025-09-02 | Sell | 15,000 | 25.00 | 375,000 | 2025-09-04 17:37:01 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2025-09-02 | Sell | 15,000 | 25.00 | 375,000 | 2025-09-04 17:37:01 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Medical Officer | 2025-08-13 | Sell | 10,000 | 20.00 | 200,000 | 2025-08-15 17:59:02 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-04-09 | Sell | 141,122 | 10.87 | 1,533,337 | 2025-04-11 18:20:07 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-03-13 | Sell | 51,425 | 15.07 | 774,975 | 2025-03-17 17:45:33 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-03-03 | Sell | 300,000 | 17.58 | 5,274,334 | 2025-03-05 18:32:06 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-03-03 | Option Exercise | 300,000 | 7.75 | 2,325,000 | 2025-03-05 18:32:06 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Directior | 2025-01-23 | Sell | 959 | 21.00 | 20,139 | 2025-01-27 19:22:57 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | 2025-01-04 | Sell | 32,729 | 19.82 | 648,824 | 2025-01-07 21:28:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2025-01-04 | Sell | 37,184 | 19.80 | 736,059 | 2025-01-07 21:28:08 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2025-01-04 | Sell | 45,167 | 19.77 | 893,095 | 2025-01-07 21:27:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2025-01-02 | Sell | 11,520 | 19.05 | 219,456 | 2025-01-06 18:07:32 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Directior | 2024-12-27 | Sell | 2,850 | 20.00 | 57,000 | 2024-12-30 17:12:21 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-12-23 | Sell | 12,563 | 19.59 | 246,109 | 2024-12-23 16:39:50 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-12-18 | Sell | 26,712 | 21.24 | 567,486 | 2024-12-20 18:04:26 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2024-12-16 | Sell | 7,495 | 21.97 | 164,665 | 2024-12-18 18:19:12 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2024-12-16 | Sell | 7,495 | 21.97 | 164,665 | 2024-12-18 18:19:12 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2024-12-16 | Sell | 5,547 | 21.91 | 121,556 | 2024-12-18 18:18:48 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2024-12-16 | Sell | 8,994 | 21.91 | 197,059 | 2024-12-18 18:15:13 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | 2024-07-02 | Sell | 9,394 | 25.28 | 237,480 | 2024-07-03 17:27:36 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2024-05-02 | Sell | 1,799 | 23.31 | 41,935 | 2024-05-06 18:04:38 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | 2024-04-01 | Sell | 6,000 | 28.03 | 168,180 | 2024-04-03 18:05:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Directior | 2024-03-18 | Buy | 3,000 | 27.66 | 82,990 | 2024-03-20 19:06:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2024-03-06 | Sell | 40,000 | 35.19 | 1,407,600 | 2024-03-08 17:54:54 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-31 | Sell | 57,499 | 32.35 | 1,860,019 | 2024-02-02 17:25:50 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-31 | Option Exercise | 57,499 | 14.54 | 836,035 | 2024-02-02 17:25:50 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | 2024-01-12 | Sell | 7,940 | 36.89 | 292,904 | 2024-01-17 18:32:24 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2024-01-11 | Sell | 2,911 | 38.06 | 110,788 | 2024-01-16 18:06:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2024-01-11 | Sell | 3,934 | 38.07 | 149,759 | 2024-01-16 18:06:38 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Directior | 2024-01-11 | Sell | 3,147 | 38.06 | 119,787 | 2024-01-16 18:06:27 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2024-01-11 | Sell | 4,720 | 38.10 | 179,813 | 2024-01-16 18:06:15 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | 2024-01-04 | Sell | 74 | 33.89 | 2,508 | 2024-01-08 17:17:32 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2024-01-04 | Sell | 16,104 | 35.27 | 567,910 | 2024-01-08 17:16:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | 2024-01-04 | Sell | 8,303 | 35.26 | 292,804 | 2024-01-08 17:16:14 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2024-01-03 | Sell | 38,443 | 34.69 | 1,333,529 | 2024-01-05 20:02:55 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2024-01-03 | Sell | 33,190 | 34.36 | 1,140,362 | 2024-01-05 19:58:47 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2024-01-02 | Sell | 9,952 | 31.01 | 308,637 | 2024-01-04 17:25:05 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-12-20 | Sell | 12,000 | 28.54 | 342,480 | 2023-12-22 17:04:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | 2023-11-20 | Sell | 19,700 | 28.80 | 567,315 | 2023-11-22 14:31:42 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-10-25 | Sell | 24,338 | 24.21 | 589,223 | 2023-10-27 18:23:41 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Directior | 2023-09-28 | Sell | 1,550 | 26.33 | 40,812 | 2023-10-02 17:51:40 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-09-18 | Sell | 57,755 | 28.12 | 1,624,223 | 2023-09-20 18:10:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-09-18 | Option Exercise | 57,755 | 4.75 | 274,336 | 2023-09-20 18:10:16 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | 2023-07-03 | Sell | 8,925 | 35.31 | 315,142 | 2023-07-06 18:04:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-06-30 | Sell | 3,000 | 35.53 | 106,590 | 2023-07-05 18:15:14 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2023-06-27 | Sell | 15,000 | 36.20 | 543,000 | 2023-06-29 18:41:22 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2023-05-05 | Sell | 6,500 | 40.90 | 265,850 | 2023-05-08 18:29:07 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-05-03 | Sell | 104,928 | 39.32 | 4,125,674 | 2023-05-05 19:04:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | 2023-05-03 | Option Exercise | 104,928 | 2.01 | 210,905 | 2023-05-05 19:04:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Directior | 2023-03-03 | Sell | 11,350 | 32.65 | 370,578 | 2023-03-06 18:04:30 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Directior | 2023-02-27 | Sell | 875 | 32.62 | 28,543 | 2023-03-01 18:14:49 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Directior | 2023-01-09 | Sell | 3,200 | 30.00 | 96,000 | 2023-01-11 20:23:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2023-01-05 | Sell | 15,000 | 37.39 | 560,850 | 2023-01-06 19:30:12 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-01-05 | Sell | 13,803 | 37.40 | 516,232 | 2023-01-06 19:24:35 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | 2023-01-03 | Sell | 17,500 | 38.33 | 670,802 | 2023-01-05 19:10:57 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | | 2023-01-03 | Sell | 10,338 | 38.38 | 396,738 | 2023-01-05 19:05:58 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | 2022-12-29 | Sell | 30,625 | 40.00 | 1,225,000 | 2022-12-30 17:12:25 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | 2022-12-21 | Option Exercise | 32,000 | 6.15 | 196,800 | 2022-12-22 20:01:04 |
